Cortexin
Кортексин
Target Organ
Brain
Description
Cortexin is a complex of water-soluble polypeptide fractions extracted from the cerebral cortex of young cattle, with molecular weights ranging from 1,000 to 10,000 Daltons. These low-molecular-weight neuropeptides are capable of crossing the blood-brain barrier and exerting tissue-specific effects on the cerebral cortex. The peptide complex modulates neuronal metabolism, regulates neurotransmitter balance (particularly serotonin, dopamine, and amino acids), and restores bioelectrical activity in the brain. Cortexin has been extensively studied in Russia for over 20 years and is used clinically for various neurological and neurodevelopmental conditions.
⚙️ Mechanism of Action
Regulates the ratio of inhibitory (GABA) and excitatory (glutamate, aspartate) amino acids, normalizes levels of serotonin and dopamine, enhances cerebral metabolism, and restores bioelectrical activity of the brain through direct action on cortical neurons.
✓ Primary Benefits
- ·Improves higher cerebral functions (memory, attention, learning)
- ·Neuroprotection against oxidative stress, hypoxia, and neurotoxins
- ·Accelerates recovery after stroke, TBI, and neurosurgery
- ·Reduces cognitive decline in neurodegenerative conditions
💊Dosing Protocol
Standard Course
10mg intramuscularly daily for 10 days (injectable form only - no capsule formulation available)
🏥Clinical Applications
Synergistic Stacks
Scientific Validation
Neuroprotective Effects of Cortexin in Traumatic Brain Injury
Clinical trial demonstrating Cortexin accelerates neurological recovery and reduces cognitive deficits following traumatic brain injury.
Cortexin in the Complex Treatment of Post-Stroke Epilepsy
Clinical study showing Cortexin reduces seizure frequency and improves EEG patterns in patients with post-stroke epilepsy.
Geroprotective Effect of Peptides in Gazprom Workers
Large-scale study on 11,000+ workers showing reduced mortality and morbidity.
Neuroprotective Effects of Cortexin in Acute Ischemic Stroke Rehabilitation
Clinical trial showing that Cortexin administration in the acute phase of ischemic stroke accelerates neurological recovery, reduces infarct volume, and improves cognitive outcomes.